$CHYM Balance Sheet | Understand Stock

$CHYM

$28.55 +$0.00 (0.0%) Close

$CHYM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Marketable securities
Product collateral
Accounts receivable, net
Loans held for investment, net
Prepaid expenses and other current assets
Total current assets
Property, equipment and software, net
Operating lease right of use assets, net
Other assets
Total assets
Liabilities and stockholders❜ equity
Current liabilities:
Accounts payable
Accrued and other current liabilities
Product obligation
Total current liabilities
Operating lease liabilities, net of current portion
Warehouse facility
Other non-current liabilities
Total liabilities
Redeemable convertible preferred stock, $0.0001 par value: No shares authorized, issued, and outstanding as of December 31, 2025. 258,613,394 shares authorized and 258,464,156 shares issued and outstanding with a liquidation preference of $2,894,515 as of December 31, 2024.
Stockholders’ equity:
Preferred stock, $0.0001 par value: 100,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025.
Common stock, issued (in share)
Common Class A
Common Class B
Class C common stock
Total common stock, issued (in share)
Common stock, outstanding (in shares)
Common Class A
Common Class B
Class C common stock
Total common stock, outstanding (in shares)
Common stock, authorized (in shares)
Common Class A
Common Class B
Class C common stock
Total common stock, authorized (in shares)
Common stock, issued
Common Stock
Common Class A
Common Class B
Class C common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Common stock, par value (in usd per share)
Common Class A
Common Class B
Class C common stock
Total common stock, par value (in usd per share)

Comments